Skip to main content
Year archive

HYUNDAI BIOSCIENCE CO., LTD. — 2020 filings

All 23 regulatory filings released by HYUNDAI BIOSCIENCE CO., LTD. (048410) in 2020, sourced directly from the official regulator.

23 Filings
2020 Period
2020 filings (23)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2020-12-15 Korean
투자판단관련주요경영사항(신약 공동개발 및 지식재산권 양수도 예약 관련 약정 체결)
M&A Activity
2020-11-26 Korean
분기보고서 (2020.09)
Interim / Quarterly Report 9M 2020
2020-11-16 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2020-11-09 Korean
[기재정정]단일판매ㆍ공급계약체결
Capital/Financing Update
2020-09-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-09-25 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-09-25 Korean
증권발행결과(자율공시)
Share Issue/Capital Change
2020-09-22 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2020-09-18 Korean
반기보고서 (2020.06)
Interim / Quarterly Report H1 2020
2020-08-14 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2020-07-01 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2020-06-17 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Q1 2020
2020-05-15 Korean
사업보고서 (2019.12)
Annual Report FY 2019
2020-03-30 Korean
정기주주총회결과(제20기)
Declaration of Voting Results & Voting Rights Announcements
2020-03-24 Korean
감사보고서제출
Audit Report / Information FY 2019
2020-03-13 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2020-03-09 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2020-03-09 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2020-03-09 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports
2020-02-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-01-13 Korean
주식등의대량보유상황보고서(일반)
Regulatory Filings
2020-01-13 Korean
전환청구권행사(제7회차)
Capital/Financing Update
2020-01-08 Korean